Home
>
National Drug Code (NDC)
>
Lithium Carbonate
Lithium Carbonate - 51079-142-20 - (lithium carbonate)
Drug Information of Lithium Carbonate
| Product NDC: | 51079-142 |
| Proprietary Name: | Lithium Carbonate |
| Non Proprietary Name: | lithium carbonate |
| Active Ingredient(s): | 450 mg/1 & nbsp; lithium carbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lithium Carbonate
| Product NDC: | 51079-142 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202219 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130404 |
Package Information of Lithium Carbonate
| Package NDC: | 51079-142-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-142-20) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51079-142-01) |
NDC Information of Lithium Carbonate
| NDC Code | 51079-142-20 |
| Proprietary Name | Lithium Carbonate |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-142-20) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51079-142-01) |
| Product NDC | 51079-142 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lithium carbonate |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130404 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | LITHIUM CARBONATE |
| Strength Number | 450 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Mood Stabilizer [EPC] |
